Company officials said Monday they are not pursuing a merger with rival Humana, causing Cigna's stock to rise in the markets.

Despite reports that merger talks were back on, Cigna officially squashed rumors that it was looking to acquire Humana in a ...

The potential merger of Cigna and Humana could have a better chance of success than under the Democrats, though we still see increasing claims concentration in the PBM industry as a concern. Also, the ...

Wiederhorn covers the Healthcare sector, focusing on stocks such as Humana, Addus Homecare ... network performance management, risk adjustment, pharmacy benefit management, analytics and performance ...

Cigna says it is not pursuing deal with rival Humana, shares rise Cigna Group ... its specialty drugs and new clients for its pharmacy benefit management unit. AXA's nine-month revenue up 7% ...

Some PBMs not cooperating with the investigation The FTC started its probe into the sector in 2022, asking the top six players in the market – CVS Caremark, Express Scripts, OptumRx, Humana ...

Humana shares drop 7% premarket as Cigna confirms it won't pursue combination with the managed care insurer.

Joyner’s comments were his first made publicly since he was promoted less than a month ago to replace Karen S. Lynch, who stepped down. CVS Health has struggled to control costs in its Aetna health ...

Purpose: The difference between what pharmacy benefit management companies (PBMs) charge prescription benefit plan sponsors and what dispensing pharmacies are paid ("spread") was studied.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...